Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novacyt S.A. buy melinda

Start price
€0.39
22.08.18 / 50%
Target price
€0.60
24.04.19
Performance (%)
-50.77%
End price
€0.19
24.04.19
Summary
This prediction ended on 24.04.19 with a price of €0.19. Massive losses of -50.77% were the result for the BUY prediction by melinda. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Novacyt S.A. - - - -
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

According to melinda what are the pros and cons of Novacyt S.A. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Novacyt S.A. diskutieren
Prediction Buy
Perf. (%) -50.77%
Target price 0.600
Change
Ends at 24.04.19

SecteurRecherche biotechnologique et médicale



métier
Logo Novacyt
Novacyt est spécialisé dans le développement, la fabrication et la commercialisation de solutions automatisées pour la cytologie. Le groupe propose des équipements et des dispositifs de cytologie de liquide aux laboratoires pour la détection des cancers notamment. Le CA par activité se répartit comme suit:
- Développement de solutions et de services de diagnostic (44,5%). Le groupe développe également une activité de fabrication de réactifs et de kits pour analyses bactériennes et sanguines;
- fabrication et vente de kits de dépistage moléculaire (40,8%, conception d'amorce): à destination des laboratoires;
- vente de solution de cytologie (14,7%): machines (automates, accessoires, pièces détachées) et consommables (flacons et systèmes de conservation).
La répartition géographique du CA est la suivante : Europe (47,4%), Asie-Pacifique (26,9%), Amérique (12,4%), Moyen Orient (8,9%) et Afrique (4,4%).



Prediction Buy
Perf. (%) -50.77%
Target price 0.600
Change
Ends at 24.04.19

(Vom Mitglied beendet)

Stopped prediction by melinda for Novacyt S.A.

buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€3.24
04.10.21
€4.50
04.10.22
-71.33%
05.10.22

Could be worthwhile Investment >10% per year
buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€3.70
31.05.20
€5.00
04.11.21
-12.32%
04.10.21

Could be worthwhile Investment >10% per year
buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€2.24
05.04.20
-
31.05.20
56.25%
31.05.20

Could be worthwhile Investment >10% per year
buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€1.52
21.03.20
-
05.04.20
41.96%
05.04.20

Could be worthwhile Investment >10% per year
buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€1.44
07.03.20
-
21.03.20
-6.13%
21.03.20

Could be worthwhile Investment >10% per year
buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€1.60
28.02.20
-
07.03.20
-21.90%
07.03.20

Could be worthwhile Investment >10% per year
buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€0.52
23.02.20
-
23.02.20
-
23.02.20

Could be worthwhile Investment >10% per year
buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€0.52
23.02.20
-
23.02.20
-
23.02.20

Could be worthwhile Investment >10% per year
buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€0.52
23.02.20
-
23.02.20
-
23.02.20

Could be worthwhile Investment >10% per year
buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€0.52
23.02.20
-
23.02.20
-
23.02.20

Could be worthwhile Investment >10% per year
buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€0.85
08.02.20
-
23.02.20
97.18%
23.02.20

Could be worthwhile Investment >10% per year
buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€0.62
07.02.20
-
08.02.20
36.44%
08.02.20

Could be worthwhile Investment >10% per year
buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€1.73
20.03.16
€2.69
20.09.16
-20.23%
20.09.16

Could be worthwhile Investment >10% per year